VINORELBINE AND CAPECITABINE as first line treatment in advanced breast cancer patients with non measurable lesions for RECIST criteria.
Phase of Trial: Phase II
Latest Information Update: 26 May 2011
At a glance
- Drugs Vinorelbine (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 26 May 2011 New trial record